Our Unit works with clinicians and other researchers on a range of global health themes across low- and middle-income countries.
The Health Economics Unit works with the clinicians and researchers on a broad range of global health related projects in low- and middle-income countries. Some of our work is methodological and considers approaches for improving current practice of cost-effectiveness analysis in low- and middle-income countries. We are also involved in clinical trials and other studies being conducted in LMICs, including carrying out economic evaluations alongside these studies. Our current collaborations include Murdoch Children’s Research Institute (MCRI) and Walter and Eliza Hall Institute of Medical Research (WEHI) and involve studies of surfactant use for newborns with respiratory distress syndrome in Fjij, the cost-effectiveness of new vaccines in the Pacific region, mass drug treatment of scabies, and interventions to reduce anaemia in infants and children.
Systems Strengthening for Effective Coverage of New Vaccines in the Pacific: cost-effectiveness analysis of HPV, RV, PCV in Samoa, Tonga, Tuvalu and Vanuatu
Mass drug administration for scabies and control of serious bacterial complications: economic evaluation alongside a before-after trial in Fiji
Benefits and safety of iron supplementation with malaria chemoprevention to children in Malawi: economic evaluation alongside a randomised controlled trial
Economic evaluation of surfactant treatment for newborns with respiratory distress syndrome in Fiji
Boujaoud MA, Mirelman AJ, Dalziel K, Carvalho N. Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries. Cost-effectiveness and Resource Allocation 2018; 16:18. https://doi.org/10.1186/s12962-018-0102-2
Carvalho N, Jit M, Cox S, Yoong J, and Hutubessy RCW. Capturing budget impact considerations within economic evaluations: A systematic review of economic evaluations of rotavirus vaccine in low- and middle-income countries and a proposed assessment framework. Pharmacoeconomics. 2017 Sep 13. doi: 10.1007/s40273-017-0569-2.
[Image credit - CDC Global - https://www.flickr.com/photos/cdcglobal/8190819087 Copyright - Creative Commons]